Sarah E. Hlavinka - 02 Jan 2025 Form 4 Insider Report for Quanterix Corp (QTRX)

Reporting relationship: Director
Issuer ticker: QTRX
Reported as of: 02 Jan 2025
Net transaction value: +$14,999
SEC form: 4
Accepted by SEC: 06 Jan 2025, 17:41:15 UTC
Prior SEC filing: 02 Oct 2024
Next SEC filing: 12 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian Keane, as Attorney-in-Fact

Key filing fact

Sarah E. Hlavinka filed Form 4 for Quanterix Corp (QTRX) on 06 Jan 2025.

Key facts

This page summarizes Sarah E. Hlavinka's Form 4 filing for Quanterix Corp (QTRX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Jan 2025, 17:41.

Change

Previous filing in this sequence was filed on 02 Oct 2024.
Current net transaction value: +$14,999.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTRX transaction

Common Stock

Award

Transaction value: $0
Shares: +7,435
Change %: +16%
Price: $0.000000
Shares after: 53,436
Date: 02 Jan 2025
Ownership: Direct
Footnotes: F1, F2

QTRX transaction

Common Stock

Award

Transaction value: $14,999
Shares: +1,394
Change %: +2.6%
Price: $10.76
Shares after: 54,830
Date: 02 Jan 2025
Ownership: Direct
Footnotes: F2, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QTRX transaction Derivative

Stock Options (Right to buy)

Award

Transaction value: $0
Shares: +15,821
Change %
Price: $0.000000
Shares after: 15,821
Date: 02 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,821
Exercise price: $10.76
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents restricted stock units that vest as to 100% of the shares on December 31, 2025 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.

Footnote F2

Includes 7,435 restricted stock units.

Footnote F3

Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2024.

Footnote F4

Closing price of the Company's common stock on the Nasdaq Global Market on January 2, 2025.

Footnote F5

Represents non-qualified stock option to purchase 15,821 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy.